Cargando…
Adverse effects of mefloquine for the treatment of uncomplicated malaria in Thailand: A pooled analysis of 19, 850 individual patients
Mefloquine (MQ) has been used for the treatment of malaria since the mid-1980s, first as monotherapy or as fixed combination with sulfadoxine-pyrimethamine (MSP) and since the mid-1990s in combination with artesunate. There is a renewed interested in MQ as part of a triple therapy for the treatment...
Autores principales: | Lee, Sue J., ter Kuile, Feiko O., Price, Ric N., Luxemburger, Christine, Nosten, François |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5305067/ https://www.ncbi.nlm.nih.gov/pubmed/28192434 http://dx.doi.org/10.1371/journal.pone.0168780 |
Ejemplares similares
-
Mefloquine for preventing malaria in pregnant women
por: González, Raquel, et al.
Publicado: (2018) -
Mefloquine for preventing malaria in pregnant women
por: González, Raquel, et al.
Publicado: (2018) -
The neurological assessment in young children treated with artesunate monotherapy or artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria
por: Ambler, Michael T, et al.
Publicado: (2009) -
Auditory assessment of patients with acute uncomplicated Plasmodium falciparum malaria treated with three-day mefloquine-artesunate on the north-western border of Thailand
por: Carrara, Verena I, et al.
Publicado: (2008) -
Mefloquine pharmacokinetics and mefloquine-artesunate effectiveness in Peruvian patients with uncomplicated Plasmodium falciparum malaria
por: Gutman, Julie, et al.
Publicado: (2009)